Is aggregated IAPP a cause of beta-cell failure in transplanted human pancreatic islets?
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Aggregation of the â-cell product islet amyloid polypeptide (IAPP) is believed to be an important event in the development of the â-cell lesion in type 2 diabetes. Preamyloidotic oligomeric IAPP assemblies exert toxic effects on â cells that die, leading to reduced â-cell mass. Normal human islets, when isolated and cultured in vitro or transplanted into nude mice, also develop amyloid deposits, which are associated with increased â-cell death and reduced â-cell mass. The possible role of IAPP aggregation and amyloid formation in loss of islet transplant function should be taken into consideration and studied further.
- Hull RL, Westermark GT, Westermark P, Kahn SE: Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab 2004, 89:3629–3643. State-of-the-art article on the importance of IAPP aggregation for the â-cell failure in type 2 diabetes. CrossRef
- Rochet JC, Lansbury PTJ: Amyloid fibrillogenesis: themes and variations. Curr Opin Struct Biol 2000, 10:60–68. CrossRef
- Kayed R, Head E, Thompson JL, et al.: Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003, 300:486–489. For those who want to get information as to why proteins aggregate into amyloid and how aggregates exert their toxicity. CrossRef
- Kayed R, Sokolov Y, Edmonds B, et al.: Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J Biol Chem 2004, 279:46363–46366. CrossRef
- Yuan J, Yankner BA: Apoptosis in the nervous system. Nature 2000, 407:802–809. CrossRef
- Westermark P, Wernstedt C, Wilander E, et al.: A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 1986, 140:827–831. CrossRef
- Westermark P, Wernstedt C, Wilander E, et al.: Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci U S A 1987, 84:3881–3885. CrossRef
- Cooper GJ, Willis AC, Clark A, et al.: Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A 1987, 84:8628–8632. CrossRef
- Wang J, Xu J, Finnerty J, et al.: The prohormone convertase enzyme 2 (PC2) is essential for processing pro-islet amyloid polypeptide at the NH2-terminal cleavage site. Diabetes 2001, 50:534–539. CrossRef
- Smeekens SP, Montag Ag, Thomas G, et al.: Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3. Proc Natl Acad Sci U S A 1992, 89:8822–8826. CrossRef
- Ward WK, LaCava EC, Paquette TL, et al.: Disproportionate elevation of immunoreactive proinsulin in type 2 (noninsulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 1987, 30:698–702. CrossRef
- Westermark P, Li ZC, Westermark GT, et al.: Effects of beta cell granule components on human islet amyloid polypeptide fibril formation. FEBS Lett 1996, 379:203–206. CrossRef
- Janciauskiene S, Eriksson S, Carlemalm E, Ahrén B: B cell granule peptides affect human islet amyloid polypeptide (IAPP) fibril formation in vitro. Biochem Biophys Res Commun 1997, 236:580–585. CrossRef
- Jaikaran ET, Clark A: Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology. Biochim Biophys Acta 2001, 1537:179–203.
- Westermark P: Amyloid and polypeptide hormones: what is their inter-relationship? Amyloid 1994, 1:47–60. CrossRef
- Westermark P, Engström U, Johnson KH, et al.: Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci U S A 1990, 87:5036–5040. CrossRef
- Westermark P, Johnson KH, O'Brien TD, Betsholtz C: Islet amyloid polypeptide-a novel controversy in diabetes research. Diabetologia 1992, 35:297–303. CrossRef
- Westermark P, Grimelius L: The pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults. Acta Pathol Microbiol Scand [A] 1973, 81:291–300.
- Clark A, Wells CA, Buley ID, et al.: Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res 1988, 9:151–159.
- Butler AE, Janson J, Bonner-Weir S, et al.: Beta-cell deficit and increase beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003, 52:102–110. CrossRef
- Howard CFJ: Longitudinal studies on the development of diabetes in individual Macaca nigra. Diabetologia 1986, 29:301–306. CrossRef
- Johnson KH, O'Brien TD, Betsholtz C, Westermark P: Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus. N Engl J Med 1989, 321:513–518. CrossRef
- Höppener JWM, Oosterwijk C, Nieuwenhuis MG, et al.: Extensive islet amyloid formation is induced by development of type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model. Diabetologia 1999, 42:427–434. CrossRef
- Verchere CB, D'Alessio DA, Palmiter RD, et al.: Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc Natl Acad Sci U S A 1996, 93:3492–3496. CrossRef
- Westermark GT, Gebre-Medhin S, Steiner DF, Westermark P: Islet amyloid development in a mouse strain lacking endogenous islet amyloid polypeptide (IAPP) but expressing human IAPP. Mol Med 2000, 6:998–1007.
- Butler AE, Janson J, Soeller WC, Butler PC: Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes 2003, 52:2304–2314. CrossRef
- Butler AE, Jang J, Gurlo T, et al.: Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes. Diabetes 2004, 53:1509–1516. CrossRef
- Ma Z, Westermark GT, Sakagashira S, et al.: Enhanced in vitro production of amyloid-like fibrils from mutant (S20G) islet amyloid polypeptide. Amyloid 2001, 8:242–249.
- Sakagashira S, Sanke T, Hanabusa T, et al.: Missense mutation of amylin gene (S20G) in Japanese NIDDM patients. Diabetes 1996, 45:1279–1281. CrossRef
- O'Brien TD, Butler AE, Roche PC, et al.: Islet amyloid polypeptide in human insulinomas. Evidence for intracellular amyloidogenesis. Diabetes 1994, 43:329–336. CrossRef
- Westermark GT, Steiner DF, Gebre-Medhin S, et al.: Pro islet amyloid polypeptide (proIAPP) immunoreactivity in amyloid formation in the islets of Langerhans. Upsala J Med Sci 2000, 105:97–106.
- Westermark P, Eizirik DL, Pipeleers DG, et al.: Rapid deposition of amyloid in human islets transplanted into nude mice. Diabetologia 1995, 38:543–549.
- Westermark GT, Westermark P, Eizirik D, et al.: Differences in amyloid deposition in islets of transgenic mice expressing human islet amyloid polypeptide versus human islets implanted into nude mice. Metabolism 1999, 48:448–454. CrossRef
- Shapiro AMJ, Lakey JRT, Ryan EA, et al.: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid free immunosuppressive regiment. N Engl J Med 2000, 343:230–238. CrossRef
- Ryan EA, Lakey JRT, Paty BW, et al.: Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 2002, 51:2148–2157. CrossRef
- Street CN, Lakey JRT, Shapiro AMJ, et al.: Islet graft assessment in the Edmonton Protocol. Implications for predicting long-term clinical outcome. Diabetes 2004, 53:3107–3114. Summarizes the present knowledge about clinical islet transplantation. CrossRef
- Eizirik DL, Pipeleers DG, Ling Z, et al.: Major species differences between man and rodents in the susceptibility to pancreatic beta-cell injury. Proc Natl Acad Sci U S A 1994, 91:9253–9256. CrossRef
- Westermark GT, Westermark P, Nordin A, et al.: Formation of amyloid in human pancreatic islets transplanted to the liver and spleen of nude mice. Upsala J Med Sci 2003, 108:193–204. One of few articles dealing with the putative role of IAPP aggregation for human islet transplant failure. CrossRef
- Kodama K, Hull RL, Wildbur S, et al.: Amyloid formation following islet transplantation is associated with increased beta-cell apoptosis, decreased beta-cell replication and reduced beta-cell volume [abstract]. Diabetes 2004, 53:A375-A376.
- Westermark G, Benig Arora M, Fox N, et al.: Amyloid formation in response to beta cell stress occurs in vitro, but not in vivo, in islets of transgenic mice expressing human islet amyloid polypeptide. Mol Med 1995, 1:542–543.
- Is aggregated IAPP a cause of beta-cell failure in transplanted human pancreatic islets?
Current Diabetes Reports
Volume 5, Issue 3 , pp 184-188
- Cover Date
- Print ISSN
- Online ISSN
- Current Medicine Group
- Additional Links